Skip to main content
Premium Trial:

Request an Annual Quote

Premier Biosoft Buys Redasoft to Expand Life Science Customer Base

Premium

Premier Biosoft has acquired privately held bioinformatics company Redasoft in an effort to expand its life sciences software business.

Redasoft markets sequence analysis software dubbed Visual Cloning, which includes vector map drawing capabilities and lets users create graphical maps based on sequence data. It also provides tools for restriction site analysis as well as to search for open reading frames.

Palo Alto, Calif.-based Premier, which is also privately held, expects the new acquisition to expand its reach in the life science software market.

“The acquisition of Redasoft demonstrates our strategy to strengthen our presence in the life science sector and deliver sustainable ... growth by offering a wide portfolio of products and services,” Kay Brown, Premier's president, said in a statement.

Premier offers software products and services for PCR and real time PCR, cloning, DNA and tissue microarrays, suspension bead arrays, glycomics, and mutagenesis. Its primary customers are government agencies, pharmaceutical and biotechnology companies, and academic researchers.

Additional details about the acquisition were not provided.

The Scan

Steps for Quick Review

The US Food and Drug Administration is preparing for the quick review of drugs and vaccines for the Omicron variant, according to the Wall Street Journal.

Moving Away From Using Term 'Race'

A new analysis finds that geneticists are using the term "race" in their papers less than in years past, as Science reports.

Point of the Program

The Guardian writes that some scientists have called the design of a UK newborn sequencing program into question.

Science Papers Present Multi-Omic Analysis of Lung Cells, Regulation of Cardiomyocyte Proliferation

In Science this week: a multi-omic analysis of lung cells focuses on RIT1-regulated pathways, and more.